Milestone Pharmaceuticals Inc. (MIST) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -16.05M | -12.78M | -9.82M | -12.57M | -13.95M | -6.84M | -7.02M | -6.05M | -8.93M | -9.8M | -12.16M | -10.56M |
| Operating CF Margin % | -6744.96% | -826.33% | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -15.06% | -86.69% | -39.87% | -107.6% | -56.17% | 30.14% | 42.29% | 42.7% | 35.75% | 23.84% | -5.07% | 25% |
| Net Income | -26.07M | -17.41M | -11.92M | -12.97M | -20.76M | -12.36M | -9.44M | -9.36M | -10.35M | -13.61M | -15.08M | -16.04M |
| Depreciation & Amortization | 56K | 34K | 25K | 28K | 27K | 26K | 25K | 26K | 28K | 26K | 24K | 24K |
| Stock-Based Compensation | 1.28M | 3.55M | 0 | 1.31M | 1.35M | 1.47M | 1.4M | 1.39M | 1.51M | 1.88M | 2.87M | 2.49M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 4.13M | 1.02M | 2.16M | 951K | 854K | 801K | 789K | 765K | 779K | 774K | 814K | 854K |
| Working Capital Changes | 4.54M | 28.39K | -78.22K | -1.89M | 4.58M | 3.22M | 208K | 1.13M | -899K | 1.14M | -789K | 2.11M |
| Change in Receivables | -1.49M | -2.02M | 501.35K | 158K | 230K | -343K | 345K | -269K | 1.73M | -1.76M | -515K | 531.72K |
| Change in Inventory | -1.18M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.09M |
| Change in Payables | 4.38M | 1.92M | 1.29M | 0 | 4.87M | 0 | 0 | 0 | -3.43M | 0 | 0 | 1.56M |
| Cash from Investing | -80.03M | 2.7M | -35.65M | 9.94M | 33.58M | 19.33M | 6.48M | 9.48M | -27.01M | 13.68M | -10.86M | -28.03M |
| Capital Expenditures | -45K | -17K | -1.98K | -11K | -6K | -22K | -4K | -7K | 0 | -31K | -18K | -31K |
| CapEx % of Revenue | 18.91% | 1.1% | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -46.36M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -28M |
| Cash from Financing | 94.35M | 36.43M | 49.66M | 36K | 140K | 24K | 74K | -298K | 32.32M | 1K | 305K | -2.77M |
| Debt Issued (Net) | 75M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 19.36M | 35.86M | 49.66M | 0 | 140K | 0 | 0 | -280K | 27.54M | 0 | 0 | 15.95K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -11K | 574.2K | 0 | 36K | 0 | 24K | 74K | -18K | 4.78M | 1K | 305K | -2.78M |
| Net Change in Cash | -1.73M | 26.36M | 4.19M | -2.59M | 19.77M | 12.52M | -463K | 3.13M | -3.63M | 3.88M | -22.71M | -41.36M |
| Free Cash Flow | -16.05M | -12.79M | -9.82M | -12.58M | -13.96M | -6.87M | -7.02M | -6.06M | -8.93M | -9.83M | -12.18M | -10.6M |
| FCF Margin % | -6744.96% | -827.04% | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -15.01% | -86.25% | -39.81% | -107.54% | -56.23% | 30.14% | 42.34% | 42.8% | 35.89% | 24.24% | -4.3% | 25.09% |
| FCF per Share | -0.12 | -0.15 | -0.15 | -0.19 | -0.21 | -0.11 | -0.11 | -0.09 | -0.18 | -0.29 | -0.28 | -0.25 |
| FCF Conversion (FCF/Net Income) | 0.62x | 0.73x | 0.82x | 0.97x | 0.67x | 0.55x | 0.74x | 0.65x | 0.86x | 0.72x | 0.81x | 0.66x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |